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Substituting the biological receptor layer from the biosensor
with a synthetic receptor opens the door for the development of
biomimetic sensors that are chemically and physically inert, as
opposed to the sensors containing biological recognition
elements. Using molecularly imprinted polymers (MIPs) the
specificity and affinity of biological receptors can bemimicked.
In addition, a MIP-based sensor can measure in harsh environ-
ments. Histamine occurs in harsh environments in food and
bodily fluids and is chosen as the target molecule for
impedimetric detection. When 10 nM histamine is present
in pH neutral environments, the impedance increases 45%withrespect to the impedance of the sensor without histamine.
Specificity is tested with respect to histidine. The influence of
the pH on the performance of the sensor is tested. In a pH range
of pH 5–12 theMIPs are stable, although they exhibit a varying
degree of protonation. The same holds true for the target
molecule ofwhich the protonation also varies with the pH of the
solution. It is shown that the pH dependent degree of
protonation of both the MIP and the histamine has a large
impact on the binding of histamine to the nanocavity in theMIP.
Hence, the detection of histamine by a MIP-based sensor is
affected by the pH of the solution. 2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1 Introduction The development of sensor devices to
detect specific molecules is of increasing importance.
Innovative biosensors make an early detection of certain
disease markingmolecules possible. Biosensors make use of
biological recognition elements, such as antibodies [1] or
enzymes [2]. However, existing sensing systems based on
biological recognition elements have restrictions limiting
their use [3, 4]. First of all, biological recognition elements
are not always available for the desired target. Furthermore,
they are unstable in organic solvents, high temperature, or
changing pH. A synthetic recognition element can be more
inert and stable in a wide range of conditions such as
temperature or pH [5].
Molecularly imprinted polymers (MIPs) are synthetic
receptors, which exhibit similar specificity and selectivity tothe desired target molecules as their natural antibodies or
enzymes [5-8]. Substituting the biological recognition
elements by a synthetic alternative creates opportunities
for the development of biomimetic sensors, which poten-
tially can be applied in harsh environments. MIPs are
polymers that contain nanocavities with the exact shape,
size, and functional groups (e.g. hydrogen bonds) comp-
lementary to their target molecule. MIPs are especially
suitable for detectionof lowmolecularweightmolecules [9, 10].
In the presence of the target molecule, binding will occur in
the nanocavities of the MIP, thereby changing the dielectric
properties of the MIP. These electrical changes can be
measured by means of impedance spectroscopy. MIPs
have successfully been integrated in impedimetric sensing
devices, such as the nicotine sensor [11], and in 2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
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[14]. An advantage of an impedimetric sensor is that it allows
for electronic data storage and analysis. Impedimetric
sensors with biological recognition elements have pre-
viously been successfully developed on polymer and
diamond transducer platforms [15, 16].
MIPs are generally believed to withstand a wide range
of pH conditions. In this article it is investigated how the pH
affects the functionality of the MIP. To this end histamine is
chosen as a relevant target molecule. Several food products
contain histamine, such as red wine, which has a pH of 3.4,
and rotten fish, which contains elevated levels of histamine.
Histamine also plays an important role in irritable bowel
syndrome (IBS) [17], allergies [18], asthma [19], rheumatoid
arthritis [20], and related diseases. For application of the
sensor in bodily fluids a chemical recognition element is
necessary, which can sustain the acidic environments of
fluids in which histamine occurs, such as stomach fluids,
bowel fluids, and saliva. As a result, the development of a
histamine sensor containing such a chemical recognition
element is of considerable interest. This is especially the case
since there is a high demand for fast tests that can detect low
concentrations of histamine under a broad range of pH
conditions.
Histamine is derived from the decarboxylation of the
amino acid histidine, a reaction which is catalyzed by the
enzyme L-histidine decarboxylase. Histamine is a small
molecule with a low molecular weight (111Da) and a
chemical formula C5H9N3 [21]. The resembling molecule
histidine is used to test specificity of the sensor. Histamine
and histidine are both depicted in Fig. 1.
Until present the following techniques have been
reported in literature for the analysis of histamine in
biological fluids. Fluorometric assays were widely used in
tissue [22] and in whole blood and plasma [23, 24, 25].
However, the measurement of a large number of samples is
complicated by the laborious extraction steps that are
needed. High-speed liquid chromatography can be used to
overcome some disadvantages of fluorometric assay,
although this requires a substantial amount of material and
time [26]. Radioisotopic enzymatic assay is a sensitive
method, which is specific in biological fluids [27], however
the presence of other compounds inhibits the enzymatic
reaction needed for this method of detection, making it
difficult to determine histamine levels. As an alternative, gas
chromatography-mass spectroscopy [28] fulfills many
sensitivity, specificity and accuracy demands. HoweverFigure 1 Chemical structure of histamine and histidine.
 2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheimsample manipulation is very complex and instrumentation
costs are very high. Other techniques are capillary electro-
phoresis (CE) [29] and high-performance liquid chromatog-
raphy (HPLC) [30].
For routine determination of histamine, an immunoassay
is suitable for the rapid analysis of large quantities of
samples. In an immunoassay histamine is detected by
binding specifically with its antibody. Preparation of such
an antibody has only become possible in 1984 [31]. The
binding of histamine to its antibody can be detected with a
radioimmunoassay (RIA). This technique is often used for a
wide range of biologically important molecules. In the mean
time, successful RIA’s for the detection of histamine have
been developed ever since [32–35]. The antibody–antigen
binding can also be detected colorimetric by means of
enzyme-linked immunosorbent assay (ELISA) [36].
Notwithstanding, considering all disadvantages of the
above-mentioned techniques it is desirable to develop a
sensor that does not require reagents, works as a direct assay,
is applicable in ‘‘point-of-care’’ context and gives a fast ‘‘real
time’’ result.
2 Materials and methods MIPs are synthesized as
follows. Amixture of methacrylic acid (MAA) (17.8mmol),
ethylene glycol dimethacrylate (EGDM) (36mmol), and
azobisisobutyronitrile (AIBN) (0.66mmol) was dissolved in
7mL dimethylsulfoxide (DMSO) together with the template
molecule histamine (8.99mmol). Thismixture was degassed
for 5min with N2 to remove oxygen. For polymerization the
solution was sealed and kept in a thermostatic oil bath at
65 8C for 12 h. After polymerization the bulk polymer was
grounded with a mechanical mortar for 24 h and sieved
through a 25-mm sieve. Only particles with a size smaller
than 25mm were used. Next, the histamine was removed
from the MIP powders by Soxhlet extraction with methanol
(48 h), followed by a mixture of acetic acid/acetonitrile (1/1)
(48 h) and finally again methanol (12 h). The extracted MIP
powders were dried in vacuum for 12 h. A schematic
representation has been made in Fig. 2. A non-imprinted
polymer (NIP) was synthesized in the same manner, but
without the presence of the target molecule.
The impedimetric sensor consists of four coplanar
aluminum electrodes of 70 nm thickness and an interspace
of 0.6mm evaporated onto glass substrates. They are coated
with a thin polymer film (200 nm) of MDMO-PPV (Poly[2-
methoxy-5-(3,7-dimethyloctyloxy)-1-4-phenylene vinylene).
This PPV-derivative is synthesized via the sulphinyl
precursor route [37, 38] and this semiconducting polymer
not only serves as a transducer layer but also as an
immobilization layer for the MIP particles. Besides MIP
particles, NIP particles also can be immobilized on the
transducer layer as reference for measuring non-specific
absorption to the polymer film. Each electrode can be
individually functionalized by applying the desired micro-
particles to the polymer layer using the stamping method.
With a polydimethylsiloxane (PDMS) stamp, with the same
shape and size of the coplanar electrode couple,www.pss-a.com
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Figure 2 Schematic representation of MIP synthesis with hista-
mine as target molecule.microparticles are placed onto the polymer surface and
placed on a hot plate at 120 8C for 10min. This temperature is
above the glass transition temperature of MDMO-PPV and
will cause the MIP and NIP particles to partially embed into
the MDMO-PPV layer. Substrates are then cooled down to
room temperature, rinsed with isopropanol to remove
excessive and non-embedded MIP and NIP microparticles
and dried under nitrogen gas.
The MIP-sensitized electrodes are integrated in an
electrochemical cell consisting of a printed circuit board
(PCB) and a 500ml Teflon reservoir on top. Contacts are
wirebonded and the reservoir contains a hole on top for easy
addition of analyte concentrations. During the measurement
the hole is covered. A PDMS ring is used between sample
and hood to prevent leaking. This electrochemicalmeasuring
device, shown in Fig. 3, contains four channels, allowing for
simultaneous reference measurements with NIPs. The
addition setup is placed in a temperature-controlled
environment (37 8C) shielded from light.
Impedance spectroscopy was performed using an
Iviumstat electrochemical analyzer from Ivium
Technologies B.V. For each sensing spot, spectra werewww.pss-a.commeasured sequentially at a low-frequency range from 1Hz to
1 kHz with zero bias voltage and an oscillating voltage of
50mV. Time-resolved analysis of the impedance spectra is
performed in the low frequency range. At low frequencies
the sensor is more sensitive for surface interactions between
the MIP binding sites, the target molecules and the
electrolyte. It is found that upon binding, electrical changes
occur at the interface [11]. A double layer is formed at the
electrode surface, which is reflected in the capacitive
changes at the lower frequency range. Even more, this
double layer affects the charge transfer from the electrolyte
to the electrode. In this most useful frequency range a
frequency of 213Hz was chosen for its optimal signal to
noise ratio and stability.
The target molecule histamine was obtained from
Aldrich. To test specificity of the MIPs the analog molecule
histidine was used, obtained from Fluka. A dilution range of
histamine and histidine is made in a phosphate buffered
saline (PBS) solution. For the dose response curve the
concentration of histamine was increased in a 0 to 12 nM
range. This is achieved by preparing a histamine concen-
tration range of 9 to 31 nM in 12 equal steps. By sequentially
adding constant volumes of 25ml of these concentrations to
the 200ml PBS inside the reservoir 1 nM increments of
concentrations are obtained from 0 to 12 nM. The histidine
concentrations were increased by repeated addition of 50ml
of a 29 nM solution, resulting in unequal steps of 5.8, 9.7, and
12.4 nM. The dose responsemeasurements occur at a pH of 7
(neutral environment).
MIPs are known to sustain acid and basic environments
very well and are therefore very suitable for application in
biosensors for measuring in vivo. Now the detection of
histamine by the MIP-based sensor is tested in various pH
environments. PBS with pH 5, 7, 9, and 12 are prepared by
adding small quantities of HCl or NaOH to the neutral buffer
solution. A histamine concentration series is created with
these PBS solutions in order to obtain three equal steps of 3, 6
and 9 nM. The three subsequent addition steps of 3, 6 and
9 nM are labeled from I to III. The fewer but larger steps
result in shorter measuring while a similar concentration
range is maintained.
3 Results and discussion To translate the chemical
recognition occurring at the MIP and NIP covered surfaces
directly into an electrical signal, impedance spectroscopy is
performed. Therefore the previously described additionFigure 3 (online color at: www.pss-a.com)
Addition setup containing a Teflon hood (left)
and a schematic representation of the cross-
section (right).
 2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
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Figure 4 Dose response curves of MIP and NIP channels in
response to addition of histamine and histidine obtained with impe-
dancemeasurements. (MIPexposedtohistamine: solidsquares;MIP
exposed to histidine: solid triangles;NIP exposed to histamine: open
squares; NIP exposed to histidine: open triangles).
Figure 5 Difference between the relative impedance signals of the
MIPchannel and theNIPchannel. The resultingfit is agoodmeasure
for the specific binding occurring at the sensor surface.
Table 1 Parameters of the allometric fit of the differential dose
response curve.
parameter fitted value
a 10.8 0.5
b 0.63 0.02
R2 0.99setup is filledwith PBS to simulate a biological environment.
After a stabilization period of 15min, increasing concen-
trations of histamine are added stepwise. Impedance spectra
are measured subsequently and out of four measured
channels the two most stable ones are chosen for analysis.
At a selected frequency of 213Hz a clear dose-response
curve is obtained in the 0–12 nM concentration range
(Fig. 4). It should be noted that all impedance data are
normalized relative to their initial impedance value, prior to
addition of the target molecule. The resulting value is
referred to as the relative impedance signal Z(t)/Z(0). A
response value is obtained 20min after addition of the target
molecule by averaging five data points of which two before
and two after the data point at 20min. The error bars obtained
in this manner are an indication for the stability of the
measured impedance signal. The actual error bars in Fig. 4
are smaller than the symbols utilized, indicating a low noise
level. At 213Hz the MIP-sensor shows a 45% response to a
concentration of 10 nM histamine. At higher concentrations
the sensor will reach its saturation level. The NIP channel,
whichmeasures non-specific binding of histaminemolecules
to the sensor surface, shows no sensitivity toward histamine.
In addition, the specificity is tested with the analog
molecule histidine. At 213Hz both theMIP and NIP channel
show no response to histidine concentrations in the same
nanomolar range. For a better graphical representation of the
specific binding events occurring at the sensor surface, the
relative impedance signal of the MIP channel is subtracted
from the relative impedance signal NIP channel, which is
associated with non-specific binding (Fig. 5). It can be seen
that the histamine MIP-sensor exhibits a 40% response to
10 nM histamine. In addition, the sensor response can be
represented by a simple allometric fit, as described by Eq.
(1), where x is the concentration of target molecule and y the
impedance signal representing the amount of targetmolecule 2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheimthat has specifically bonded to the MIP.y ¼ axb: (1)Anallometric fit reflects a typical binding isotherm.Each
binding site has a different affinity and such heterogeneous
distribution of the binding sites results in a binding isotherm
which is best analyzed with the Freundlich model, displayed
in Eq. (2) [11 and references there in]. In this model q is the
amount of bound target molecules per gram of adsorbent
(MIP) andCf the concentration of free targetmolecules in the
supernatant fluid. Kf is the Freundlich constant and n the
Freundlich heterogeneity parameter. The fitted values are
displayed in Table 1.q ¼ KfCnf : (2)For the envisioned application in bodyfluids the sensor is
tested under various pH conditions. The results are shown in
Fig. 6. In an acidic solution of pH 5 the sensor exhibits no
response to the addition of histamine in both theMIP channel
and the NIP channel (Fig. 6a). In neutral environments
(pH7), theMIP channel exhibits a response to the subsequent
additions of histamine, while the NIP channel does not
exhibit non-specific absorption (Fig. 6b). When a concen-
tration of 9 nM is present in the setup, the signal has increased
12% after 20min. This is similar to the observations in the
dose-response experiments described previously. However,
in a basic solution of pH 9 the sensor exhibits an increased
response (Fig. 6c). When the concentration is increased towww.pss-a.com
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Figure 6 Relative impedance signal of MIP and NIP channels
in response to addition of histamine under various pH conditions:
(a) pH 5, (b) pH 7, (c) pH 9, and (d) pH 12. Additions of 3 nM, 6Nm,
and 9 nM are labeled I, II, and III, respectively. (MIP exposed to
histamine: solid squares; NIP exposed to histamine: open squares).
www.pss-a.com9 nM in the third addition step, after 20min the sensor signal
increases 60%. Also the NIP channel shows very little non-
specific absorption. Finally, the same measurement has been
performed in a more basic environment of pH 12 (Fig. 6d).
Both signals remain constant after the first addition. After the
second and third addition step both the MIP and the NIP
channel show a slight signal drift, caused by minor
disturbances in the addition setup when analyte is added.
Most importantly, in this experiment no specific response of
the MIP channel is noticeable as a result of the three
subsequent addition steps.
This pH dependency of the sensor response can be
explained by the behavior of the target molecule and theMIP
in varying pH conditions. The appearance of certain
molecules depends on the pH of the solution in which it is
dissolved [39]. In an acidic environment protons from the
solution might bind to molecules, resulting in protonated
molecules. This ionization occurs at a specific pH value.
Histamine has pKa values of 6.9 and 10.4 [40], which are
improved values as compared to the ones previously reported
in the literature [41]. A third pKa value of about 15–20 has
been reported, but this value is less relevant since it does not
fall within the pH range of aqueous solutions [40]. The
behavior of histamine in various pH solutions is modeled
with hyperquad simulation and speciation (HySS) [42],
which can be used for the investigation of equilibria
involving soluble and partially soluble species. The result
is depicted in Fig. 7.
In solution, histamine becomes protonated at specific
sites. They are depicted in Fig. 8. In strongly basic
environments above pH 10.4, histamine will be predomi-
nantly present in its neutral form (Fig. 1). Upon lowering
the pH, the aliphatic amino group will be able to increasingly
bind a proton, creating single-protonated histamine or
histamineþ. At pH 10.4, when the pH is exactly the pKa
value, the neutral histamine and the single-protonated
histamine are present in equal concentrations. In neutral
environments (pH 7) histamine is still mostly present in its
single protonated form. However, decreasing the pH of the
buffer solution will further increase the protonation of
histamine. At lower pH, the imidazole ring can bind a proton
and hence a double protonated form of histamine,
histamineþþwill be formed. At pH 6.9 the single protonated
and double protonated histamine are present in equal
concentrations. Below pH 6.9 double protonated histamine
is predominant in the buffer solution. Not only the histamine
will be affected by changing the pH, but also the MIP will
exhibit protonation and deprotonation reactions. As a model
for the MIP, PMAA, poly methacrylic acid, can be used,
which can be obtained from the same monomer, i.e. MAA,
which is also used to make the MIP. PMMA has a pKa value
between 6 and 7 [43]. Its protonation behavior can also be
modeled using HySS as depicted in Fig. 9.
For a successful selective binding event of histamine to
theMIP, at least one, but preferablymore, hydrogen bond has
to be formed between histamine and the MIP. This binding
will ultimately result in detection in the sensor. However, the 2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
842 E. Bongaers et al.: A MIP-based biomimetic sensor for impedimetric detection of histamine
p
h
ys
ic
a ssp status solid
i a
Figure 9 Equilibriumofpolymer in solutions,modeledwithHySS
[41].Figure 7 (online color at: www.pss-a.com) Equilibrium of an
aqueous solution of histamine at varying pH values, modeled with
HySS [42].formation of hydrogen bonds is strongly pH dependent,
which explains the results from Fig. 6 as follows. In buffer
solutions of pH 5, histamine is mostly double protonated
(histamineþþ) and there are almost no histamineþmolecules
left. Since in such acidic solutions also the MIP is almost
fully protonated, only very weak hydrogen bonding is
possible between the target molecule and the MIP. As a
result, the molecule now is unlikely to bind to the nanocavity
of the MIP and hence the sensor shows no response to
addition of this molecule. At pH 7 the MIP is partially
deprotonated. At the same time, about 44% of the histamine
remains double protonated, while the remainder has become
single protonated. The histamineþ and the histamineþþ
molecules can form hydrogen bonds with the partially
deprotonated MIP. As a result, the sensor shows a good
response at pH 7.Figure 8 (online color at: www.pss-a.com) Protonation sites of
histamine [40].
 2010 WILEY-VCH Verlag GmbH & Co. KGaA, WeinheimAt even higher pH (pH 9) histamineþ is predominant,
while the MIP is now almost fully deprotonated. This allows
the formation of a hydrogen bond and thus the sensor shows a
strong response. It is assumed that this condition is close to
the optimal balance between protonation of histamine and
deprotonation of the polymer.
At pH 12 histamineþ has mostly been converted
into neutral histamine, which is now the predominant
molecule. Since, both histamine and the MIP have
deprotonized, no large amount of hydrogen bonds can
be formed. The MIP channel shows no response to the
analyte addition at a pH of 12 and no specific match with the
nanocavity is established.
The long-term stability of this sensor needs to be further
tested.
4 Conclusion A fast and specific test has been
developed for detecting low concentrations of histamine in
the nanomolar range. For example, typical physiological
conditions in mast cells are around 200 nM. The impedi-
metric MIP-based sensor has a limit of detection of 2 nM.
The sensitivity is 45% to 10 nM histamine. A dose response
curve is measured in the 0–12 nM range. Specificity was
confirmed by tests with histidine, showing no significant
sensor response.
The detection of the MIP-based sensor is affected by
the pHof the environment.Although theMIP canwithstand a
wide range of pH values, the pH of the electrolyte affects
protonation or deprotonation of target molecule and MIP.
This has a substantial impact on the formation of hydrogen
bonds, which are needed for binding of the targetmolecule to
the MIP.
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